Colony-stimulating factors and antibiotics---a new prospect in treating infectious diseases?

Suppr

超能文献

作者信息

Schneider Christian M., Daschner Franz D.

机构信息

Institute for Environmental Medicine and Hospital Epidemiology, University Hospital Freiburg, Freiburg, Germany.

出版信息

Clin Microbiol Infect. 1998 Mar;4(3):119-122. doi: 10.1111/j.1469-0691.1998.tb00373.x.

DOI:10.1111/j.1469-0691.1998.tb00373.x

PMID:11864304

Abstract

摘要

相似文献

Colony-stimulating factors and antibiotics---a new prospect in treating infectious diseases?

Clin Microbiol Infect. 1998 Mar;4(3):119-122. doi: 10.1111/j.1469-0691.1998.tb00373.x.

SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disorders.

Expert Rev Hematol. 2018 Feb;11(2):155-168. doi: 10.1080/17474086.2018.1420472. Epub 2018 Jan 3.

Colony stimulating factors for chemotherapy induced febrile neutropenia.

Cochrane Database Syst Rev. 2003(3):CD003039. doi: 10.1002/14651858.CD003039.

Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.

J Infect Dis. 2002 May 15;185(10):1490-501. doi: 10.1086/340221. Epub 2002 Apr 19.

Febrile neutropenia: highlighting the role of prophylactic antibiotics and granulocyte colony-stimulating factor during standard dose chemotherapy for solid tumors.

Anticancer Drugs. 2006 Sep;17(8):881-9. doi: 10.1097/01.cad.0000224455.46824.b5.

Granulocyte colony-stimulating factor and antibiotics in the prophylaxis of a murine model of polymicrobial peritonitis and sepsis.

J Infect Dis. 1998 Aug;178(2):471-7. doi: 10.1086/515643.

A new bioassay for human granulocyte colony-stimulating factor (hG-CSF) using murine myeloblastic NFS-60 cells as targets and estimation of its levels in sera from normal healthy persons and patients with infectious and hematological disorders.

Exp Hematol. 1989 Feb;17(2):116-9.

Colony-stimulating factors for the management of neutropenia in cancer patients.

Drugs. 2002;62 Suppl 1:1-15. doi: 10.2165/00003495-200262001-00001.

Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients.

Curr Opin Organ Transplant. 2008 Dec;13(6):575-80. doi: 10.1097/MOT.0b013e3283186b80.

"Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.

J Control Release. 2011 Dec 10;156(2):128-45. doi: 10.1016/j.jconrel.2011.07.002. Epub 2011 Jul 6.

引用本文的文献

Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review.

Pharmaceuticals (Basel). 2023 Nov 15;16(11):1615. doi: 10.3390/ph16111615.

A School-Based Educational Intervention for School-Aged Children and Caregivers about Rational Use of Antibiotics in Urban Areas of Shaanxi Province: A Study Protocol for a Randomized Controlled Research.

Int J Environ Res Public Health. 2018 Sep 3;15(9):1912. doi: 10.3390/ijerph15091912.

A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia.

Support Care Cancer. 2004 Oct;12(10):725-30. doi: 10.1007/s00520-004-0658-6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验